Background Image
Table of Contents Table of Contents
Previous Page  1 / 48 Next Page
Information
Show Menu
Previous Page 1 / 48 Next Page
Page Background

Featured in this issue:

Volume 12 Number 1

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

Pearinda 4.

Each tablet contains 4 mg perindopril

tert

-butylamine. Reg. No.: RSA S3 41/7.1.3/0649. NAM NS2 10/7.1.3/0476.

Pearinda 8.

Each tablet contains

8 mgperindopril

tert

-butylamine.Reg.No

.:RSAS341/7.1.3/0650.NAMNS210/7.1.3/0477.For fullprescribing information, refer to thepackage insertapproved

by the Medicines Control Council, April 2009.

Pearinda Plus 4.

Each tablet contains 4 mg perindopril

tert

-butylamine and 1,25 mg indapamide. Reg. No.: RSA

S3 41/7.1.3/0633. NAM NS2 10/7.1.3/0611. For full prescribing information, refer to the package insert approved by the Medicines Control Council, April 2010.

1)

The EUROPA study Investigators. “Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:

randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study)”. The Lancet 2003;362:782-788.

2)

The PREAMI study Investigators.

“Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodelling and clinical outcome. Results of the randomized perindopril

and remodelling in elderly with acute myocardial infarction (PREAMI) study”. Arch Intern Med 2006;166:659-666.

3)

PROGRESS Collaborative Group.

“Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack”.

The Lancet 2001;358:1033-41.

4)

Guerin AP,

et al.

“Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure”. Circulation

2001;103;987-992. 5) Department of Health website

http://www.doh.gov.za

– Accessed on 26/03/2015.

PAE178/06/2015.

Perindopril has proven outcomes in:

đŏ +.+* .5ŏ .0!.5ŏ %/! /!

1

đŏ 10!ŏ 5+ . % (ŏ *" . 0%+*

2

đŏ 0.+'!

3

đŏ * ġ/0 #!ŏ !* (ŏ %(1.!

4

!! ŏ

endurance

3$!*ŏ0.! 0%*#

ŏ %/! /!ĕ

0$!ŏ ""+. (!

5

endurance

ġ%*$% %0+.

Pearinda CVJA ofc.indd 1

2015/07/28 11:36 AM

July 2015

SAJDVD

The South African Journal of Diabetes & Vascular Disease

Reviews

Ethics Focus

Achieving Best Practice Diabetes Educator’s Focus

News

The electronic version of

the journal is available at

www.diabetesjournal.co.za

Lifestyle and diet

Carbohydrates versus fat in

the diet

Stem cell therapies for

neuropathic pain

Diabetes and male

reproductive function

Prevalence of dyslipidaemia

in statin-treated patients

Gender and ethnic

differences in

hyperlipidaemia

Metabolic syndrome and

waist circumference in

Angola